{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T07:48:06Z","timestamp":1719474486279},"reference-count":28,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2004,12,22]],"date-time":"2004-12-22T00:00:00Z","timestamp":1103673600000},"content-version":"vor","delay-in-days":21,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Nephrology"],"published-print":{"date-parts":[[2004,12]]},"abstract":"<jats:title>SUMMARY:<\/jats:title><jats:p><jats:bold>Background:\u2003<\/jats:bold> Henoch\u2013Schonlein purpura (HSP) is a vasculitic syndrome with palpable purpura and renal involvement. The treatment for HSP with persistent renal disease remains controversial. The kidney biopsy in HSP shows IgA deposits and fish\u2010oil therapy has proven to be promising in halting the progression of IgA nephropathy.<\/jats:p><jats:p><jats:bold>Methods:\u2003<\/jats:bold> Five children with biopsy\u2010proven HSP with repeated episodes of haematuria and proteinuria were treated with fish oil \u200a(1\u2003g \u200aorally \u200atwice \u200adaily). \u200aIn \u200athree \u200aof \u200athe \u200afive \u200apatients \u200aan \u200aangiotensin\u2010converting enzyme inhibitor (ACEI) was added for hypertension.<\/jats:p><jats:p><jats:bold>Results:\u2003<\/jats:bold> The mean duration of follow up after starting fish\u2010oil therapy was 49.2\u2003weeks. The protein excretion rate prior to starting fish oil was 1041\u2003mg\/day and on the last follow\u2010up visit the rate had decreased to 104\u2003mg\/day (<jats:italic>P\u2003&lt;<\/jats:italic>\u20030.05). The average blood pressure (BP) prior to therapy was 135\/82. On the last follow\u2010up visit the average BP off ACEI had decreased to 100\/54 (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05). After a year of follow up serum creatinine and glomerular filtration rates have remained stable at 51.2\u2003\u00b5mol\/L and 128\u2003mL\/min\/1.73\u2003m<jats:sup>2<\/jats:sup>, respectively.<\/jats:p><jats:p><jats:bold>Conclusion:\u2003<\/jats:bold> This is the first report of abatement of HSP with fish oil and ACEI in children. There is a need for randomized prospective trials to confirm this observation.<\/jats:p>","DOI":"10.1111\/j.1440-1797.2004.00320.x","type":"journal-article","created":{"date-parts":[[2004,12,22]],"date-time":"2004-12-22T10:57:54Z","timestamp":1103713074000},"page":"381-386","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Managing Henoch\u2013Schonlein purpura in children with fish oil and ACE inhibitor therapy"],"prefix":"10.1111","volume":"9","author":[{"given":"MEHUL P","family":"DIXIT","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NAZNIN M","family":"DIXIT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KATHERINE","family":"SCOTT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,12,22]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-200101000-00006"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004670050707"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004670050446"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000013883.99976.22"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00869111"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(86)80771-5"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004670000517"},{"key":"e_1_2_6_9_2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00467-003-1132-2","article-title":"Renal biopsy 2\u20139 years after Henoch Schonlein purpura","volume":"18","author":"Algoet C","year":"2003","journal-title":"Pediatr. Nephrol."},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1159\/000424001"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)36972-8"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004670000309"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199411033311804"},{"key":"e_1_2_6_14_2","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1681\/ASN.V1081772","article-title":"The long\u2010term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial","volume":"10","author":"Donadio JV","year":"1999","journal-title":"J. Am. Soc. Nephrol."},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.50.7.463"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0952-3278(95)90090-X"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1079\/BJN2001459"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/132.2.261"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0031-3955(16)36251-4"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199911000-00005"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01958961"},{"key":"e_1_2_6_22_2","first-page":"9","article-title":"Response of crescentic Henoch\u2013Schoenlein purpura nephritis to corticosteroid and azathioprine therapy","volume":"49","author":"Bergstein J","year":"1998","journal-title":"Clin. Nephrol."},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-003-1315-x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00868294"},{"key":"e_1_2_6_25_2","first-page":"61","article-title":"Cyclosporin A therapy for steroid\u2010dependent Henoch\u2013Schonlein purpura","volume":"36","author":"Huang DC","year":"2003","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1011068108595"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1079\/PNS19980074"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(12)61725-X"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/71.1.373s"}],"container-title":["Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1797.2004.00320.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1797.2004.00320.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T15:21:35Z","timestamp":1696951295000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1797.2004.00320.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["10.1111\/j.1440-1797.2004.00320.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1797.2004.00320.x","archive":["Portico"],"relation":{},"ISSN":["1320-5358","1440-1797"],"issn-type":[{"value":"1320-5358","type":"print"},{"value":"1440-1797","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12]]},"assertion":[{"value":"2004-12-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}